Joel E. Tepper, MD, on Radiotherapy in Liver and Pancreatic Cancers

2015 ASTRO Annual Meeting
Tweet this page

Joel E. Tepper, MD, of the University of North Carolina School of Medicine, discusses the ways in which SBRT has changed radiotherapy, as demonstrated in key studies presented at this year's meeting on stereotactic body radiotherapy for liver metastases and hepatocellular carcinoma, and borderline resectable and unresectable pancreatic tumors (Abstracts 253, 255, 351, 357).

Advertisement

Advertisement



Advertisement